New results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study showed that a combination of pembrolizumab and concurrent chemoradiotherapy (CCRT) continues to ...
Linda R. Duska, gynecologic oncologist, University of Virginia, discusses the Foundation for Women's Cancer. Linda R. Duska, gynecologic oncologist, University of Virginia, discusses the Foundation ...
For years, doctors, public health experts and researchers have known the risk of dying from cancer is substantially higher if a patient lives in a rural area compared to an urban area. Now, two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results